nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Leukocytosis—Ramipril—coronary artery disease	0.00439	0.00439	CcSEcCtD
Capreomycin—Hearing impaired—Ramipril—coronary artery disease	0.00433	0.00433	CcSEcCtD
Capreomycin—Eosinophilia—Fenofibrate—coronary artery disease	0.00428	0.00428	CcSEcCtD
Capreomycin—Hypokalaemia—Eplerenone—coronary artery disease	0.00427	0.00427	CcSEcCtD
Capreomycin—Urticaria—Tirofiban—coronary artery disease	0.00423	0.00423	CcSEcCtD
Capreomycin—Body temperature increased—Tirofiban—coronary artery disease	0.00421	0.00421	CcSEcCtD
Capreomycin—Eosinophilia—Clopidogrel—coronary artery disease	0.00421	0.00421	CcSEcCtD
Capreomycin—Eosinophilia—Lovastatin—coronary artery disease	0.00418	0.00418	CcSEcCtD
Capreomycin—Renal impairment—Telmisartan—coronary artery disease	0.00414	0.00414	CcSEcCtD
Capreomycin—Hepatocellular injury—Ramipril—coronary artery disease	0.00412	0.00412	CcSEcCtD
Capreomycin—Eosinophilia—Ezetimibe—coronary artery disease	0.0041	0.0041	CcSEcCtD
Capreomycin—Oliguria—Lisinopril—coronary artery disease	0.00406	0.00406	CcSEcCtD
Capreomycin—Deafness—Furosemide—coronary artery disease	0.00404	0.00404	CcSEcCtD
Capreomycin—Eosinophilia—Eplerenone—coronary artery disease	0.00401	0.00401	CcSEcCtD
Capreomycin—Leukocytosis—Lisinopril—coronary artery disease	0.00398	0.00398	CcSEcCtD
Capreomycin—Hypersensitivity—Tirofiban—coronary artery disease	0.00392	0.00392	CcSEcCtD
Capreomycin—Eosinophilia—Simvastatin—coronary artery disease	0.00391	0.00391	CcSEcCtD
Capreomycin—Renal impairment—Perindopril—coronary artery disease	0.00391	0.00391	CcSEcCtD
Capreomycin—Hypokalaemia—Olmesartan—coronary artery disease	0.00391	0.00391	CcSEcCtD
Capreomycin—Renal failure—Fenofibrate—coronary artery disease	0.00379	0.00379	CcSEcCtD
Capreomycin—Renal failure—Clopidogrel—coronary artery disease	0.00372	0.00372	CcSEcCtD
Capreomycin—Eosinophilia—Olmesartan—coronary artery disease	0.00367	0.00367	CcSEcCtD
Capreomycin—Renal impairment—Losartan—coronary artery disease	0.00367	0.00367	CcSEcCtD
Capreomycin—Urticaria—Pitavastatin—coronary artery disease	0.00361	0.00361	CcSEcCtD
Capreomycin—Tinnitus—Acetylsalicylic acid—coronary artery disease	0.00361	0.00361	CcSEcCtD
Capreomycin—Hypokalaemia—Telmisartan—coronary artery disease	0.00359	0.00359	CcSEcCtD
Capreomycin—Renal failure—Eplerenone—coronary artery disease	0.00355	0.00355	CcSEcCtD
Capreomycin—Vertigo—Gemfibrozil—coronary artery disease	0.00355	0.00355	CcSEcCtD
Capreomycin—Eosinophilia—Pravastatin—coronary artery disease	0.00353	0.00353	CcSEcCtD
Capreomycin—Leukopenia—Gemfibrozil—coronary artery disease	0.00353	0.00353	CcSEcCtD
Capreomycin—Vertigo—Ticagrelor—coronary artery disease	0.00346	0.00346	CcSEcCtD
Capreomycin—Eosinophilia—Trandolapril—coronary artery disease	0.00343	0.00343	CcSEcCtD
Capreomycin—Eosinophilia—Enalapril—coronary artery disease	0.00342	0.00342	CcSEcCtD
Capreomycin—Eosinophilia—Telmisartan—coronary artery disease	0.00337	0.00337	CcSEcCtD
Capreomycin—Hypersensitivity—Pitavastatin—coronary artery disease	0.00335	0.00335	CcSEcCtD
Capreomycin—Deafness—Ramipril—coronary artery disease	0.00334	0.00334	CcSEcCtD
Capreomycin—Hypokalaemia—Furosemide—coronary artery disease	0.00329	0.00329	CcSEcCtD
Capreomycin—Eosinophilia—Captopril—coronary artery disease	0.00328	0.00328	CcSEcCtD
Capreomycin—Renal failure—Valsartan—coronary artery disease	0.00327	0.00327	CcSEcCtD
Capreomycin—Renal failure—Olmesartan—coronary artery disease	0.00325	0.00325	CcSEcCtD
Capreomycin—Pain—Penbutolol—coronary artery disease	0.00323	0.00323	CcSEcCtD
Capreomycin—Eosinophilia—Perindopril—coronary artery disease	0.00318	0.00318	CcSEcCtD
Capreomycin—Tinnitus—Clopidogrel—coronary artery disease	0.00317	0.00317	CcSEcCtD
Capreomycin—Thrombocytopenia—Gemfibrozil—coronary artery disease	0.00315	0.00315	CcSEcCtD
Capreomycin—Renal impairment—Ramipril—coronary artery disease	0.00314	0.00314	CcSEcCtD
Capreomycin—Eosinophilia—Furosemide—coronary artery disease	0.00309	0.00309	CcSEcCtD
Capreomycin—Renal failure—Trandolapril—coronary artery disease	0.00304	0.00304	CcSEcCtD
Capreomycin—Vertigo—Acetylsalicylic acid—coronary artery disease	0.00303	0.00303	CcSEcCtD
Capreomycin—Renal failure—Enalapril—coronary artery disease	0.00303	0.00303	CcSEcCtD
Capreomycin—Tinnitus—Eplerenone—coronary artery disease	0.00302	0.00302	CcSEcCtD
Capreomycin—Leukopenia—Acetylsalicylic acid—coronary artery disease	0.00302	0.00302	CcSEcCtD
Capreomycin—Eosinophilia—Losartan—coronary artery disease	0.00299	0.00299	CcSEcCtD
Capreomycin—Renal failure—Telmisartan—coronary artery disease	0.00298	0.00298	CcSEcCtD
Capreomycin—Body temperature increased—Penbutolol—coronary artery disease	0.00298	0.00298	CcSEcCtD
Capreomycin—Renal failure—Captopril—coronary artery disease	0.0029	0.0029	CcSEcCtD
Capreomycin—Rash—Pitavastatin—coronary artery disease	0.00287	0.00287	CcSEcCtD
Capreomycin—Dermatitis—Pitavastatin—coronary artery disease	0.00286	0.00286	CcSEcCtD
Capreomycin—Renal impairment—Lisinopril—coronary artery disease	0.00285	0.00285	CcSEcCtD
Capreomycin—Renal failure—Perindopril—coronary artery disease	0.00282	0.00282	CcSEcCtD
Capreomycin—Thrombocytopenia—Rosuvastatin—coronary artery disease	0.00277	0.00277	CcSEcCtD
Capreomycin—Pain—Gemfibrozil—coronary artery disease	0.00275	0.00275	CcSEcCtD
Capreomycin—Renal failure—Furosemide—coronary artery disease	0.00274	0.00274	CcSEcCtD
Capreomycin—Vertigo—Fenofibrate—coronary artery disease	0.00271	0.00271	CcSEcCtD
Capreomycin—Tinnitus—Niacin—coronary artery disease	0.00271	0.00271	CcSEcCtD
Capreomycin—Leukopenia—Fenofibrate—coronary artery disease	0.0027	0.0027	CcSEcCtD
Capreomycin—Thrombocytopenia—Acetylsalicylic acid—coronary artery disease	0.00269	0.00269	CcSEcCtD
Capreomycin—Tinnitus—Pravastatin—coronary artery disease	0.00266	0.00266	CcSEcCtD
Capreomycin—Vertigo—Clopidogrel—coronary artery disease	0.00266	0.00266	CcSEcCtD
Capreomycin—Leukopenia—Clopidogrel—coronary artery disease	0.00265	0.00265	CcSEcCtD
Capreomycin—Renal failure—Losartan—coronary artery disease	0.00264	0.00264	CcSEcCtD
Capreomycin—Vertigo—Lovastatin—coronary artery disease	0.00264	0.00264	CcSEcCtD
Capreomycin—Leukopenia—Lovastatin—coronary artery disease	0.00263	0.00263	CcSEcCtD
Capreomycin—Tinnitus—Trandolapril—coronary artery disease	0.00259	0.00259	CcSEcCtD
Capreomycin—Tinnitus—Enalapril—coronary artery disease	0.00258	0.00258	CcSEcCtD
Capreomycin—Eosinophilia—Ramipril—coronary artery disease	0.00256	0.00256	CcSEcCtD
Capreomycin—Urticaria—Gemfibrozil—coronary artery disease	0.00256	0.00256	CcSEcCtD
Capreomycin—Tinnitus—Telmisartan—coronary artery disease	0.00254	0.00254	CcSEcCtD
Capreomycin—Body temperature increased—Ticagrelor—coronary artery disease	0.00249	0.00249	CcSEcCtD
Capreomycin—Vertigo—Simvastatin—coronary artery disease	0.00247	0.00247	CcSEcCtD
Capreomycin—Leukopenia—Simvastatin—coronary artery disease	0.00246	0.00246	CcSEcCtD
Capreomycin—Pain—Rosuvastatin—coronary artery disease	0.00242	0.00242	CcSEcCtD
Capreomycin—Thrombocytopenia—Fenofibrate—coronary artery disease	0.00241	0.00241	CcSEcCtD
Capreomycin—Tinnitus—Perindopril—coronary artery disease	0.0024	0.0024	CcSEcCtD
Capreomycin—Thrombocytopenia—Lovastatin—coronary artery disease	0.00235	0.00235	CcSEcCtD
Capreomycin—Vertigo—Valsartan—coronary artery disease	0.00233	0.00233	CcSEcCtD
Capreomycin—Tinnitus—Furosemide—coronary artery disease	0.00233	0.00233	CcSEcCtD
Capreomycin—Vertigo—Olmesartan—coronary artery disease	0.00232	0.00232	CcSEcCtD
Capreomycin—Eosinophilia—Lisinopril—coronary artery disease	0.00232	0.00232	CcSEcCtD
Capreomycin—Hypersensitivity—Ticagrelor—coronary artery disease	0.00232	0.00232	CcSEcCtD
Capreomycin—Leukopenia—Olmesartan—coronary artery disease	0.00231	0.00231	CcSEcCtD
Capreomycin—Thrombocytopenia—Ezetimibe—coronary artery disease	0.00231	0.00231	CcSEcCtD
Capreomycin—Vertigo—Niacin—coronary artery disease	0.00227	0.00227	CcSEcCtD
Capreomycin—Renal failure—Ramipril—coronary artery disease	0.00227	0.00227	CcSEcCtD
Capreomycin—Leukopenia—Niacin—coronary artery disease	0.00226	0.00226	CcSEcCtD
Capreomycin—Tinnitus—Losartan—coronary artery disease	0.00225	0.00225	CcSEcCtD
Capreomycin—Urticaria—Rosuvastatin—coronary artery disease	0.00225	0.00225	CcSEcCtD
Capreomycin—Vertigo—Pravastatin—coronary artery disease	0.00223	0.00223	CcSEcCtD
Capreomycin—Leukopenia—Pravastatin—coronary artery disease	0.00223	0.00223	CcSEcCtD
Capreomycin—Thrombocytopenia—Simvastatin—coronary artery disease	0.0022	0.0022	CcSEcCtD
Capreomycin—Urticaria—Acetylsalicylic acid—coronary artery disease	0.00219	0.00219	CcSEcCtD
Capreomycin—Vertigo—Trandolapril—coronary artery disease	0.00217	0.00217	CcSEcCtD
Capreomycin—Leukopenia—Trandolapril—coronary artery disease	0.00216	0.00216	CcSEcCtD
Capreomycin—Vertigo—Enalapril—coronary artery disease	0.00216	0.00216	CcSEcCtD
Capreomycin—Leukopenia—Enalapril—coronary artery disease	0.00215	0.00215	CcSEcCtD
Capreomycin—Vertigo—Telmisartan—coronary artery disease	0.00213	0.00213	CcSEcCtD
Capreomycin—Pain—Fenofibrate—coronary artery disease	0.0021	0.0021	CcSEcCtD
Capreomycin—Hypersensitivity—Rosuvastatin—coronary artery disease	0.00209	0.00209	CcSEcCtD
Capreomycin—Thrombocytopenia—Valsartan—coronary artery disease	0.00208	0.00208	CcSEcCtD
Capreomycin—Pain—Clopidogrel—coronary artery disease	0.00207	0.00207	CcSEcCtD
Capreomycin—Thrombocytopenia—Olmesartan—coronary artery disease	0.00207	0.00207	CcSEcCtD
Capreomycin—Renal failure—Lisinopril—coronary artery disease	0.00206	0.00206	CcSEcCtD
Capreomycin—Pain—Lovastatin—coronary artery disease	0.00205	0.00205	CcSEcCtD
Capreomycin—Rash—Gemfibrozil—coronary artery disease	0.00203	0.00203	CcSEcCtD
Capreomycin—Dermatitis—Gemfibrozil—coronary artery disease	0.00203	0.00203	CcSEcCtD
Capreomycin—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.00203	0.00203	CcSEcCtD
Capreomycin—Pain—Ezetimibe—coronary artery disease	0.00201	0.00201	CcSEcCtD
Capreomycin—Vertigo—Perindopril—coronary artery disease	0.00201	0.00201	CcSEcCtD
Capreomycin—Leukopenia—Perindopril—coronary artery disease	0.00201	0.00201	CcSEcCtD
Capreomycin—Thrombocytopenia—Pravastatin—coronary artery disease	0.00199	0.00199	CcSEcCtD
Capreomycin—Rash—Ticagrelor—coronary artery disease	0.00198	0.00198	CcSEcCtD
Capreomycin—Dermatitis—Ticagrelor—coronary artery disease	0.00198	0.00198	CcSEcCtD
Capreomycin—Pain—Eplerenone—coronary artery disease	0.00197	0.00197	CcSEcCtD
Capreomycin—Vertigo—Furosemide—coronary artery disease	0.00196	0.00196	CcSEcCtD
Capreomycin—Urticaria—Fenofibrate—coronary artery disease	0.00195	0.00195	CcSEcCtD
Capreomycin—Leukopenia—Furosemide—coronary artery disease	0.00195	0.00195	CcSEcCtD
Capreomycin—Body temperature increased—Fenofibrate—coronary artery disease	0.00194	0.00194	CcSEcCtD
Capreomycin—Thrombocytopenia—Trandolapril—coronary artery disease	0.00193	0.00193	CcSEcCtD
Capreomycin—Tinnitus—Ramipril—coronary artery disease	0.00193	0.00193	CcSEcCtD
Capreomycin—Thrombocytopenia—Enalapril—coronary artery disease	0.00192	0.00192	CcSEcCtD
Capreomycin—Pain—Simvastatin—coronary artery disease	0.00192	0.00192	CcSEcCtD
Capreomycin—Urticaria—Clopidogrel—coronary artery disease	0.00192	0.00192	CcSEcCtD
Capreomycin—Body temperature increased—Clopidogrel—coronary artery disease	0.00191	0.00191	CcSEcCtD
Capreomycin—Urticaria—Lovastatin—coronary artery disease	0.00191	0.00191	CcSEcCtD
Capreomycin—Body temperature increased—Lovastatin—coronary artery disease	0.0019	0.0019	CcSEcCtD
Capreomycin—Thrombocytopenia—Telmisartan—coronary artery disease	0.0019	0.0019	CcSEcCtD
Capreomycin—Vertigo—Losartan—coronary artery disease	0.00189	0.00189	CcSEcCtD
Capreomycin—Tinnitus—Timolol—coronary artery disease	0.00189	0.00189	CcSEcCtD
Capreomycin—Leukopenia—Losartan—coronary artery disease	0.00188	0.00188	CcSEcCtD
Capreomycin—Urticaria—Ezetimibe—coronary artery disease	0.00187	0.00187	CcSEcCtD
Capreomycin—Body temperature increased—Ezetimibe—coronary artery disease	0.00186	0.00186	CcSEcCtD
Capreomycin—Thrombocytopenia—Captopril—coronary artery disease	0.00184	0.00184	CcSEcCtD
Capreomycin—Body temperature increased—Eplerenone—coronary artery disease	0.00182	0.00182	CcSEcCtD
Capreomycin—Hypersensitivity—Fenofibrate—coronary artery disease	0.00181	0.00181	CcSEcCtD
Capreomycin—Pain—Olmesartan—coronary artery disease	0.0018	0.0018	CcSEcCtD
Capreomycin—Thrombocytopenia—Perindopril—coronary artery disease	0.00179	0.00179	CcSEcCtD
Capreomycin—Rash—Rosuvastatin—coronary artery disease	0.00179	0.00179	CcSEcCtD
Capreomycin—Dermatitis—Rosuvastatin—coronary artery disease	0.00178	0.00178	CcSEcCtD
Capreomycin—Urticaria—Simvastatin—coronary artery disease	0.00178	0.00178	CcSEcCtD
Capreomycin—Hypersensitivity—Clopidogrel—coronary artery disease	0.00178	0.00178	CcSEcCtD
Capreomycin—Body temperature increased—Simvastatin—coronary artery disease	0.00178	0.00178	CcSEcCtD
Capreomycin—Hypersensitivity—Lovastatin—coronary artery disease	0.00177	0.00177	CcSEcCtD
Capreomycin—Pain—Niacin—coronary artery disease	0.00176	0.00176	CcSEcCtD
Capreomycin—Tinnitus—Lisinopril—coronary artery disease	0.00175	0.00175	CcSEcCtD
Capreomycin—Thrombocytopenia—Furosemide—coronary artery disease	0.00174	0.00174	CcSEcCtD
Capreomycin—Pain—Pravastatin—coronary artery disease	0.00174	0.00174	CcSEcCtD
Capreomycin—Rash—Acetylsalicylic acid—coronary artery disease	0.00174	0.00174	CcSEcCtD
Capreomycin—Hypersensitivity—Ezetimibe—coronary artery disease	0.00173	0.00173	CcSEcCtD
Capreomycin—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.00173	0.00173	CcSEcCtD
Capreomycin—Urticaria—Valsartan—coronary artery disease	0.00168	0.00168	CcSEcCtD
Capreomycin—Thrombocytopenia—Losartan—coronary artery disease	0.00168	0.00168	CcSEcCtD
Capreomycin—Urticaria—Olmesartan—coronary artery disease	0.00168	0.00168	CcSEcCtD
Capreomycin—Body temperature increased—Olmesartan—coronary artery disease	0.00167	0.00167	CcSEcCtD
Capreomycin—Pain—Telmisartan—coronary artery disease	0.00166	0.00166	CcSEcCtD
Capreomycin—Hypersensitivity—Simvastatin—coronary artery disease	0.00165	0.00165	CcSEcCtD
Capreomycin—Urticaria—Niacin—coronary artery disease	0.00164	0.00164	CcSEcCtD
Capreomycin—Body temperature increased—Niacin—coronary artery disease	0.00163	0.00163	CcSEcCtD
Capreomycin—Vertigo—Ramipril—coronary artery disease	0.00162	0.00162	CcSEcCtD
Capreomycin—Leukopenia—Ramipril—coronary artery disease	0.00161	0.00161	CcSEcCtD
Capreomycin—Urticaria—Pravastatin—coronary artery disease	0.00161	0.00161	CcSEcCtD
Capreomycin—Body temperature increased—Pravastatin—coronary artery disease	0.0016	0.0016	CcSEcCtD
Capreomycin—Vertigo—Timolol—coronary artery disease	0.00158	0.00158	CcSEcCtD
Capreomycin—Urticaria—Trandolapril—coronary artery disease	0.00157	0.00157	CcSEcCtD
Capreomycin—Pain—Perindopril—coronary artery disease	0.00156	0.00156	CcSEcCtD
Capreomycin—Hypersensitivity—Valsartan—coronary artery disease	0.00156	0.00156	CcSEcCtD
Capreomycin—Urticaria—Enalapril—coronary artery disease	0.00156	0.00156	CcSEcCtD
Capreomycin—Body temperature increased—Trandolapril—coronary artery disease	0.00156	0.00156	CcSEcCtD
Capreomycin—Body temperature increased—Enalapril—coronary artery disease	0.00155	0.00155	CcSEcCtD
Capreomycin—Rash—Fenofibrate—coronary artery disease	0.00155	0.00155	CcSEcCtD
Capreomycin—Dermatitis—Fenofibrate—coronary artery disease	0.00155	0.00155	CcSEcCtD
Capreomycin—Urticaria—Telmisartan—coronary artery disease	0.00154	0.00154	CcSEcCtD
Capreomycin—Body temperature increased—Telmisartan—coronary artery disease	0.00153	0.00153	CcSEcCtD
Capreomycin—Rash—Clopidogrel—coronary artery disease	0.00152	0.00152	CcSEcCtD
Capreomycin—Dermatitis—Clopidogrel—coronary artery disease	0.00152	0.00152	CcSEcCtD
Capreomycin—Pain—Furosemide—coronary artery disease	0.00152	0.00152	CcSEcCtD
Capreomycin—Hypersensitivity—Niacin—coronary artery disease	0.00152	0.00152	CcSEcCtD
Capreomycin—Rash—Lovastatin—coronary artery disease	0.00151	0.00151	CcSEcCtD
Capreomycin—Dermatitis—Lovastatin—coronary artery disease	0.00151	0.00151	CcSEcCtD
Capreomycin—Hypersensitivity—Pravastatin—coronary artery disease	0.0015	0.0015	CcSEcCtD
Capreomycin—Body temperature increased—Captopril—coronary artery disease	0.00149	0.00149	CcSEcCtD
Capreomycin—Rash—Ezetimibe—coronary artery disease	0.00148	0.00148	CcSEcCtD
Capreomycin—Dermatitis—Ezetimibe—coronary artery disease	0.00148	0.00148	CcSEcCtD
Capreomycin—Vertigo—Lisinopril—coronary artery disease	0.00147	0.00147	CcSEcCtD
Capreomycin—Pain—Losartan—coronary artery disease	0.00147	0.00147	CcSEcCtD
Capreomycin—Leukopenia—Lisinopril—coronary artery disease	0.00146	0.00146	CcSEcCtD
Capreomycin—Rash—Eplerenone—coronary artery disease	0.00145	0.00145	CcSEcCtD
Capreomycin—Urticaria—Perindopril—coronary artery disease	0.00145	0.00145	CcSEcCtD
Capreomycin—Hypersensitivity—Trandolapril—coronary artery disease	0.00145	0.00145	CcSEcCtD
Capreomycin—Dermatitis—Eplerenone—coronary artery disease	0.00145	0.00145	CcSEcCtD
Capreomycin—Hypersensitivity—Enalapril—coronary artery disease	0.00145	0.00145	CcSEcCtD
Capreomycin—Body temperature increased—Perindopril—coronary artery disease	0.00145	0.00145	CcSEcCtD
Capreomycin—Thrombocytopenia—Ramipril—coronary artery disease	0.00144	0.00144	CcSEcCtD
Capreomycin—Hypersensitivity—Telmisartan—coronary artery disease	0.00143	0.00143	CcSEcCtD
Capreomycin—Rash—Simvastatin—coronary artery disease	0.00142	0.00142	CcSEcCtD
Capreomycin—Dermatitis—Simvastatin—coronary artery disease	0.00141	0.00141	CcSEcCtD
Capreomycin—Urticaria—Furosemide—coronary artery disease	0.00141	0.00141	CcSEcCtD
Capreomycin—Body temperature increased—Furosemide—coronary artery disease	0.00141	0.00141	CcSEcCtD
Capreomycin—Urticaria—Losartan—coronary artery disease	0.00136	0.00136	CcSEcCtD
Capreomycin—Body temperature increased—Losartan—coronary artery disease	0.00136	0.00136	CcSEcCtD
Capreomycin—Rash—Valsartan—coronary artery disease	0.00134	0.00134	CcSEcCtD
Capreomycin—Dermatitis—Valsartan—coronary artery disease	0.00134	0.00134	CcSEcCtD
Capreomycin—Rash—Olmesartan—coronary artery disease	0.00133	0.00133	CcSEcCtD
Capreomycin—Dermatitis—Olmesartan—coronary artery disease	0.00133	0.00133	CcSEcCtD
Capreomycin—Hypersensitivity—Furosemide—coronary artery disease	0.00131	0.00131	CcSEcCtD
Capreomycin—Thrombocytopenia—Lisinopril—coronary artery disease	0.00131	0.00131	CcSEcCtD
Capreomycin—Rash—Niacin—coronary artery disease	0.0013	0.0013	CcSEcCtD
Capreomycin—Dermatitis—Niacin—coronary artery disease	0.0013	0.0013	CcSEcCtD
Capreomycin—Rash—Pravastatin—coronary artery disease	0.00128	0.00128	CcSEcCtD
Capreomycin—Dermatitis—Pravastatin—coronary artery disease	0.00128	0.00128	CcSEcCtD
Capreomycin—Hypersensitivity—Losartan—coronary artery disease	0.00126	0.00126	CcSEcCtD
Capreomycin—Rash—Trandolapril—coronary artery disease	0.00124	0.00124	CcSEcCtD
Capreomycin—Dermatitis—Trandolapril—coronary artery disease	0.00124	0.00124	CcSEcCtD
Capreomycin—Rash—Enalapril—coronary artery disease	0.00124	0.00124	CcSEcCtD
Capreomycin—Dermatitis—Enalapril—coronary artery disease	0.00124	0.00124	CcSEcCtD
Capreomycin—Pain—Timolol—coronary artery disease	0.00123	0.00123	CcSEcCtD
Capreomycin—Rash—Telmisartan—coronary artery disease	0.00122	0.00122	CcSEcCtD
Capreomycin—Dermatitis—Telmisartan—coronary artery disease	0.00122	0.00122	CcSEcCtD
Capreomycin—Rash—Captopril—coronary artery disease	0.00119	0.00119	CcSEcCtD
Capreomycin—Dermatitis—Captopril—coronary artery disease	0.00119	0.00119	CcSEcCtD
Capreomycin—Urticaria—Ramipril—coronary artery disease	0.00117	0.00117	CcSEcCtD
Capreomycin—Body temperature increased—Ramipril—coronary artery disease	0.00116	0.00116	CcSEcCtD
Capreomycin—Rash—Perindopril—coronary artery disease	0.00115	0.00115	CcSEcCtD
Capreomycin—Dermatitis—Perindopril—coronary artery disease	0.00115	0.00115	CcSEcCtD
Capreomycin—Urticaria—Timolol—coronary artery disease	0.00114	0.00114	CcSEcCtD
Capreomycin—Pain—Lisinopril—coronary artery disease	0.00114	0.00114	CcSEcCtD
Capreomycin—Body temperature increased—Timolol—coronary artery disease	0.00114	0.00114	CcSEcCtD
Capreomycin—Rash—Furosemide—coronary artery disease	0.00112	0.00112	CcSEcCtD
Capreomycin—Dermatitis—Furosemide—coronary artery disease	0.00112	0.00112	CcSEcCtD
Capreomycin—Hypersensitivity—Ramipril—coronary artery disease	0.00108	0.00108	CcSEcCtD
Capreomycin—Rash—Losartan—coronary artery disease	0.00108	0.00108	CcSEcCtD
Capreomycin—Dermatitis—Losartan—coronary artery disease	0.00108	0.00108	CcSEcCtD
Capreomycin—Urticaria—Lisinopril—coronary artery disease	0.00106	0.00106	CcSEcCtD
Capreomycin—Hypersensitivity—Timolol—coronary artery disease	0.00106	0.00106	CcSEcCtD
Capreomycin—Body temperature increased—Lisinopril—coronary artery disease	0.00105	0.00105	CcSEcCtD
Capreomycin—Hypersensitivity—Lisinopril—coronary artery disease	0.000983	0.000983	CcSEcCtD
Capreomycin—Rash—Ramipril—coronary artery disease	0.000927	0.000927	CcSEcCtD
Capreomycin—Dermatitis—Ramipril—coronary artery disease	0.000926	0.000926	CcSEcCtD
Capreomycin—Rash—Timolol—coronary artery disease	0.000906	0.000906	CcSEcCtD
Capreomycin—Dermatitis—Timolol—coronary artery disease	0.000906	0.000906	CcSEcCtD
Capreomycin—Rash—Lisinopril—coronary artery disease	0.000841	0.000841	CcSEcCtD
Capreomycin—Dermatitis—Lisinopril—coronary artery disease	0.00084	0.00084	CcSEcCtD
